International Patent: VIRAL VECTOR-BASED GENE THERAPY FOR OPA1 GENE MUTATION-INDUCED DOMINANT OPTIC ATROPHY

GENEVA, June 19 -- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA filed a patent application (US2025/055119) for “VIRAL VECTOR-BASED GENE THERAPY FOR OPA1 GENE MUTATION-INDUCED DOMINANT OPTIC ATROPHY”. With publication no. WO/2026/107047, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/85

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....